Gilead Sciences, Inc. (GILD) Key Metrics
GILD valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $193.67B
- Enterprise value
- $212.37B
- P/E (TTM)
- — 10-yr median 18.0
- Forward P/E
- 15.6
- PEG ratio
- 2.27
- Price / sales
- 6.4 10-yr median 3.7
- Price / book
- 16.0 10-yr median 4.5
- EV / EBITDA
- 117.8 10-yr median 11.7
- Dividend yield
- 2.10% $3.28 a year
- Beta
- 0.33
GILD key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsGILD valuation Price multiples at each fiscal year-end price.
GILD returns How much profit the business earns on the capital it uses.
GILD per-share figures Results divided by the shares outstanding at year-end.
GILD financial health Debt, liquidity and how easily interest is covered.
GILD efficiency & capital use Working capital cycle and where the cash goes.
GILD valuation history
GILD returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
GILD debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
GILD cash returned to shareholders
GILD price vs earnings per share
GILD key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $154.04B | $115.92B | $101.91B | $108.34B | $91.63B | $73.58B | $82.98B | $81.82B | $94.49B | $97.25B |
| Enterprise value | $169.36B | $131.07B | $119.63B | $127.19B | $111.81B | $97.58B | $83.22B | $79.05B | $102.53B | $92.62B |
| P/E ratio | 18.1 | 241.5 | 18.0 | 23.6 | 14.7 | 598.2 | 15.4 | 15.0 | 20.4 | 7.2 |
| Price / sales | 5.2 | 4.0 | 3.8 | 4.0 | 3.4 | 3.0 | 3.7 | 3.7 | 3.6 | 3.2 |
| Price / book | 6.8 | 6.0 | 4.5 | 5.1 | 4.3 | 4.0 | 3.7 | 3.8 | 4.6 | 5.0 |
| Price / free cash flow | 16.3 | 11.2 | 13.7 | 13.0 | 8.5 | 9.8 | 10.0 | 10.9 | 8.4 | 6.0 |
| Price / operating cash flow | 15.4 | 10.7 | 12.7 | 11.9 | 8.0 | 9.0 | 9.1 | 9.7 | 7.9 | 5.7 |
| EV / sales | 5.8 | 4.6 | 4.4 | 4.7 | 4.1 | 4.0 | 3.7 | 3.6 | 3.9 | 3.0 |
| EV / EBITDA | 12.5 | 29.6 | 15.7 | 14.4 | 9.9 | 23.6 | 11.0 | 7.7 | 6.4 | 4.8 |
| EV / free cash flow | 17.9 | 12.7 | 16.1 | 15.2 | 10.3 | 13.0 | 10.0 | 10.6 | 9.1 | 5.7 |
| Earnings yield | 5.5% | 0.4% | 5.6% | 4.2% | 6.8% | 0.2% | 6.5% | 6.7% | 4.9% | 13.9% |
| Free cash flow yield | 6.1% | 8.9% | 7.3% | 7.7% | 11.8% | 10.2% | 10.0% | 9.1% | 12.0% | 16.8% |
| Dividend yield | 2.6% | 3.4% | 3.7% | 3.4% | 3.9% | 4.7% | 3.9% | 3.6% | 2.9% | 2.5% |
| Shareholder yield (dividends + buybacks) | 3.8% | 4.4% | 4.7% | 4.7% | 4.5% | 6.8% | 6.0% | 7.2% | 3.9% | 13.8% |
| Share price at fiscal year-end | $122.74 | $92.37 | $81.01 | $85.85 | $72.61 | $58.26 | $64.98 | $62.55 | $71.64 | $71.61 |
| Per share | ||||||||||
| Revenue per share | $23.46 | $22.91 | $21.55 | $21.62 | $21.64 | $19.55 | $17.58 | $16.92 | $19.79 | $22.38 |
| Earnings per share | $6.78 | $0.38 | $4.50 | $3.64 | $4.93 | $0.10 | $4.22 | $4.17 | $3.51 | $9.94 |
| Operating cash flow per share | $7.98 | $8.63 | $6.36 | $7.19 | $9.02 | $6.47 | $7.16 | $6.42 | $9.02 | $12.55 |
| Free cash flow per share | $7.53 | $8.21 | $5.90 | $6.61 | $8.56 | $5.95 | $6.51 | $5.72 | $8.57 | $12.00 |
| Cash per share | $7.66 | $9.22 | $5.77 | $5.06 | $5.17 | $5.87 | $19.07 | $23.00 | $19.34 | $23.84 |
| Book value per share | $18.09 | $15.40 | $18.15 | $16.83 | $16.69 | $14.41 | $17.64 | $16.35 | $15.50 | $14.26 |
| Tangible book value per share | −$2.06 | −$7.12 | −$9.49 | −$12.65 | −$16.42 | −$18.24 | $3.62 | $1.17 | −$0.62 | $6.79 |
| Dividends per share | $3.19 | $3.12 | $3.03 | $2.94 | $2.86 | $2.73 | $2.52 | $2.27 | $2.07 | $1.81 |
| Capex per share | $0.45 | $0.42 | $0.47 | $0.58 | $0.46 | $0.51 | $0.65 | $0.71 | $0.45 | $0.55 |
| Debt per share | $19.87 | $21.28 | $19.86 | $19.99 | $21.15 | $24.86 | $19.26 | $20.89 | $25.43 | $20.44 |
| Shares outstanding | 1.25B | 1.25B | 1.26B | 1.26B | 1.26B | 1.26B | 1.28B | 1.31B | 1.32B | 1.36B |
| Change in shares outstanding | 0.0% | −0.2% | −0.3% | 0.0% | −0.1% | −1.1% | −2.4% | −0.8% | −2.9% | −10.7% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 40.5% | 2.3% | 25.7% | 21.7% | 31.7% | 0.6% | 24.5% | 26.1% | 23.3% | 70.2% |
| Return on invested capital (ROIC) | 28.0% | 3.1% | 18.9% | 14.2% | 17.8% | 6.3% | 20.7% | 24.4% | 32.7% | 96.5% |
| Return on assets (ROA) | 14.4% | 0.8% | 9.0% | 7.0% | 9.1% | 0.2% | 8.6% | 8.1% | 7.3% | 24.8% |
| Return on tangible assets | 25.2% | 1.6% | 20.7% | 17.7% | 23.8% | 0.5% | 12.3% | 12.4% | 9.4% | 28.8% |
| Free cash flow margin | 32.1% | 35.8% | 27.4% | 30.6% | 39.6% | 30.5% | 37.1% | 33.8% | 43.3% | 53.6% |
| Income quality (OCF / net income) | 1.18 | 22.56 | 1.41 | 1.98 | 1.83 | 66.41 | 1.70 | 1.54 | 2.57 | 1.26 |
| Financial health | ||||||||||
| Total debt | $24.94B | $26.71B | $24.99B | $25.23B | $26.70B | $31.40B | $24.59B | $27.32B | $33.54B | $27.75B |
| Cash & short-term investments | $9.61B | $11.57B | $7.26B | $6.38B | $6.52B | $7.41B | $24.35B | $30.09B | $25.51B | $32.38B |
| Net debt | $15.32B | $15.14B | $17.72B | $18.84B | $20.18B | $23.99B | $241.0M | −$2.77B | $8.03B | −$4.63B |
| Debt / equity | 1.10 | 1.38 | 1.09 | 1.19 | 1.27 | 1.73 | 1.09 | 1.28 | 1.64 | 1.43 |
| Debt / assets | 0.42 | 0.45 | 0.40 | 0.40 | 0.39 | 0.46 | 0.40 | 0.43 | 0.48 | 0.49 |
| Net debt / EBITDA | 1.13 | 3.42 | 2.33 | 2.13 | 1.78 | 5.81 | 0.03 | −0.27 | 0.50 | −0.24 |
| Current ratio | 1.55 | 1.60 | 1.43 | 1.29 | 1.27 | 1.40 | 3.10 | 3.38 | 2.74 | 4.17 |
| Quick ratio | 1.40 | 1.45 | 1.27 | 1.15 | 1.13 | 1.26 | 3.01 | 3.30 | 2.67 | 4.00 |
| Interest coverage | 11.4 | 1.7 | 8.1 | 7.8 | 9.9 | 4.1 | 4.3 | 7.6 | 12.6 | 18.3 |
| Working capital | $6.53B | $7.17B | $4.80B | $3.21B | $3.16B | $4.60B | $20.54B | $25.23B | $20.19B | $29.26B |
| Invested capital | $38.02B | $34.47B | $40.56B | $40.09B | $41.24B | $42.20B | $22.77B | $18.62B | $28.47B | $14.74B |
| Tangible asset value | −$2.67B | −$9.02B | −$12.02B | −$16.00B | −$20.72B | −$23.01B | $4.75B | $1.68B | −$758.0M | $9.22B |
| Net current asset value | −$18.06B | −$20.58B | −$23.29B | −$27.52B | −$32.12B | −$34.19B | −$8.68B | −$6.30B | −$17.96B | $867.0M |
| Graham number | $52.53 | $11.51 | $42.88 | $37.12 | $43.05 | $5.62 | $40.91 | $39.17 | $34.98 | $56.48 |
| Graham net-net per share | −$17.71 | −$19.13 | −$22.04 | −$24.75 | −$28.68 | −$30.30 | −$8.99 | −$7.00 | −$15.91 | −$0.78 |
| Capital allocation | ||||||||||
| Dividends paid | $4.00B | $3.92B | $3.81B | $3.71B | $3.60B | $3.45B | $3.22B | $2.97B | $2.73B | $2.46B |
| Share buybacks (net) | $1.92B | $1.15B | $1.00B | $1.40B | $546.0M | $1.58B | $1.75B | $2.90B | $954.0M | $11.00B |
| Dividend payout ratio | 47.0% | 816.2% | 67.2% | 80.8% | 57.9% | — | 59.8% | 54.5% | 59.0% | 18.2% |
| Dividends + buybacks / free cash flow | 62.7% | 49.2% | 64.8% | 61.2% | 38.4% | 66.9% | 59.8% | 78.5% | 32.6% | 82.6% |
| Capex / revenue | 1.9% | 1.8% | 2.2% | 2.7% | 2.1% | 2.6% | 3.7% | 4.2% | 2.3% | 2.5% |
| Capex / operating cash flow | 5.6% | 4.8% | 7.3% | 8.0% | 5.1% | 8.0% | 9.0% | 11.0% | 5.0% | 4.4% |
| Capex / depreciation | 0.20 | 0.19 | 0.22 | 0.35 | 0.28 | 0.44 | 0.59 | 0.65 | 0.46 | 0.65 |
| Stock-based compensation / revenue | 3.0% | 2.9% | 2.8% | 2.3% | 2.3% | 2.6% | 2.8% | 3.8% | 2.4% | 1.3% |
| R&D / revenue | 19.7% | 20.5% | 21.1% | 18.2% | 16.9% | 20.4% | 18.1% | 17.7% | 14.3% | 16.8% |
| SG&A / revenue | 19.4% | 21.2% | 24.0% | 20.8% | 19.2% | 20.7% | 19.5% | 18.3% | 14.9% | 11.2% |
| Efficiency | ||||||||||
| Days sales outstanding | 57.9 | 57.6 | 63.5 | 62.0 | 62.7 | 62.6 | 56.2 | 59.2 | 58.5 | 62.3 |
| Days of inventory on hand | 102.0 | 102.1 | 103.6 | 100.8 | 91.3 | 104.0 | 67.8 | 60.7 | 99.7 | 151.7 |
| Days payables outstanding | 45.3 | 40.4 | 45.8 | 51.9 | 42.8 | 62.2 | 58.7 | 60.3 | 84.3 | 102.1 |
| Cash conversion cycle (days) | 114.5 | 119.3 | 121.3 | 110.9 | 111.2 | 104.5 | 65.3 | 59.6 | 73.8 | 111.9 |
| Receivables turnover | 6.31 | 6.33 | 5.75 | 5.89 | 5.82 | 5.83 | 6.50 | 6.17 | 6.24 | 5.86 |
| Payables turnover | 8.05 | 9.04 | 7.98 | 7.03 | 8.52 | 5.87 | 6.22 | 6.05 | 4.33 | 3.57 |
| Inventory turnover | 3.58 | 3.58 | 3.52 | 3.62 | 4.00 | 3.51 | 5.39 | 6.01 | 3.66 | 2.41 |
| Asset turnover | 0.50 | 0.47 | 0.43 | 0.42 | 0.40 | 0.38 | 0.36 | 0.33 | 0.41 | 0.56 |
| Average receivables | $4.67B | $4.54B | $4.72B | $4.63B | $4.69B | $4.24B | $3.45B | $3.59B | $4.18B | $5.18B |
| Average payables | $774.0M | $691.5M | $727.5M | $805.0M | $774.5M | $778.5M | $751.5M | $802.0M | $1.01B | $1.19B |
| Average inventory | $1.74B | $1.75B | $1.65B | $1.56B | $1.65B | $1.30B | $868.0M | $807.5M | $1.19B | $1.77B |
| Intangibles / total assets | 42.9% | 47.9% | 56.0% | 58.9% | 61.5% | 60.3% | 29.1% | 31.2% | 30.2% | 17.8% |
Computed from GILD's annual financial statements (latest annual report filed February 24, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
GILD valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Gilead traded at 18.1 times earnings, against a 10-year median of 18.0. Gilead earned a return on equity of 40.5% and a return on invested capital of 28.0% in fiscal 2025. It ended the year with $24.9 billion of debt and $9.6 billion in cash and short-term investments, net debt of $15.3 billion. It returned $5.9 billion to shareholders: $4.0 billion in dividends and $1.9 billion in share buybacks, 63% of free cash flow. The share count fell 7.6% from 1.36B to 1.25B over 9 years.
See the GILD income statement, the GILD chart for price history, or the GILD stock overview for the latest quote and news.
GILD key metrics FAQ
What is Gilead's P/E ratio?
Gilead traded at 18.1 times earnings at the end of fiscal 2025.
What is Gilead's EV/EBITDA?
Gilead's enterprise value was 12.5 times EBITDA at the end of fiscal 2025 (enterprise value $169.4 billion, EBITDA $13.6 billion); the current EV/EBITDA is 117.8.
What is Gilead's return on equity?
Gilead's return on equity (ROE) was 40.5% in fiscal 2025: net income of $8.5 billion on average shareholders' equity of $21.0 billion.
What is Gilead's ROIC?
Gilead's return on invested capital was 28.0% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Gilead have?
Gilead had total debt of $24.9 billion at the end of fiscal 2025, a debt-to-equity ratio of 1.10 and $15.3 billion of net debt (1.13 times EBITDA).
What is Gilead's dividend yield?
Gilead's forward dividend yield is 2.10%. Gilead paid $4.0 billion in dividends in fiscal 2025 ($3.19 per share), a payout ratio of 47.0%.
Does Gilead buy back its shares?
Yes. Gilead spent $1.9 billion on net share repurchases in fiscal 2025 Shares outstanding changed 0.0% over the year, to 1.25B..
What is Gilead's free cash flow yield?
Gilead generated $9.5 billion of free cash flow in fiscal 2025, a free cash flow yield of 6.1% on its market value at year-end ($154.0 billion).
What is Gilead's current ratio?
Gilead's current ratio was 1.55 at the end of fiscal 2025: current assets were 1.55 times current liabilities.